All Stories

  1. The estimated impact of mandatory front-of-pack nutrition labelling policies on adult obesity prevalence and obesity-related mortality in England: a modelling study
  2. The estimated health and economic impacts of the introduction of taxation and warning labelling on foods high in fat, sugar or salt in England: A microsimulation study
  3. Quantifying the contributions of cardiovascular risk factors to cardiovascular disease trends in 21st century Japan: a microsimulation study
  4. Estimating the health impact of menu calorie labelling policy and sugar-sweetened beverage taxation in two European countries: a microsimulation study
  5. Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data
  6. The estimated impact of mandatory front-of-pack nutrition labelling policies on adult obesity prevalence and cardiovascular mortality in England: a modelling study
  7. Can the HEARTS initiative reduce the burden of cardiovascular disease?
  8. Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study
  9. Quantifying the mental health and economic impacts of prospective Universal Basic Income schemes among young people in the UK: a microsimulation modelling study
  10. Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques
  11. Promotion of healthy nutrition in primary and secondary cardiovascular disease prevention: a clinical consensus statement from the European Association of Preventive Cardiology
  12. Projections of future coronary heart disease and stroke mortality in Japan until 2040: a Bayesian age-period-cohort analysis
  13. Impact of Total Hip Replacements on the Incidence of Hip Fractures in Norway During 1999–2019. A NOREPOS Study
  14. Commentary: Growing urban and rural inequalities: looking at the heart to reduce the gap
  15. Tobacco Control Policy Simulation Models: Protocol for a Systematic Methodological Review
  16. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users
  17. Tobacco Control Policy Simulation Models: Protocol for a Systematic Methodological Review (Preprint)
  18. Multimorbidity: the case for prevention
  19. Evaluating stakeholder involvement in building a decision support tool for NHS health checks: co-producing the WorkHORSE study
  20. The QUEST for Effective and Equitable Policies to Prevent Non-communicable Diseases: Co-Production Lessons From Stakeholder Workshops
  21. Análisis del descenso de muertes por enfermedad coronaria entre 1995 y 2010. Estudio IMPACT CHD Argentina
  22. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK
  23. Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model
  24. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis
  25. Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach
  26. Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study
  27. Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study
  28. Erratum to “Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach” [Int. J. Cardiol. 207 (2016) 286–291]
  29. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options
  30. The effects of maximising the UK’s tobacco control score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study
  31. Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments
  32. Response to Letter Regarding Article, “Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women”
  33. Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach
  34. Modeling Future Cardiovascular Disease Mortality in the United StatesCLINICAL PERSPECTIVE
  35. Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study
  36. Keeping Public Health Clean: Food Policy Barriers and Opportunities in the Era of the Industrial Epidemics
  37. Future trends and inequalities in premature coronary deaths in England: Modelling study
  38. An opportunity to reduce the burdens and inequalities in cardiovascular disease and gastric cancer caused by dietary salt: IMPACTNCD microsimulation study
  39. Modelling Future Coronary Heart Disease Mortality to 2030 in the British Isles
  40. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study
  41. Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact
  42. Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011CLINICAL PERSPECTIVE
  43. Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study
  44. Health of the UK population in 2040
  45. Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast
  46. The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast
  47. Modelling the Health Impact of an English Sugary Drinks Duty at National and Local Levels
  48. Declining trends in acute myocardial infarction attack and mortality rates, celebrating progress and ensuring future success
  49. Decline in Coronary Mortality in Sweden between 1986 and 2002: Comparing Contributions from Primary and Secondary Prevention
  50. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact
  51. Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991 - 2012: A Modelling Study
  52. A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study
  53. Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach
  54. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study
  55. Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model
  56. Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach
  57. Smorgasbord or symphony? Assessing public health nutrition policies across 30 European countries using a novel framework
  58. Cardiovascular risk factor trends in the Eastern Mediterranean region: evidence from four countries is alarming
  59. An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study
  60. Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010–2020
  61. Future Declines of Coronary Heart Disease Mortality in England and Wales Could Counter the Burden of Population Ageing
  62. Fruit and vegetable consumption and non-communicable disease: time to update the ‘5 a day’ message?
  63. Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies
  64. Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data
  65. Continuing decrease in coronary heart disease mortality in Sweden
  66. A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries
  67. Effect of health insurance on the utilisation of allied health services by people with chronic disease: a systematic review and meta-analysis
  68. Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios
  69. Salt reduction as a population-based intervention for the prevention of coronary heart diseases: an economic assessment
  70. Reduction in myocardial infarction admissions in Liverpool after the smoking ban: potential socioeconomic implications for policymaking
  71. Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008
  72. Public health nutrition actions across 14 EU countries: a qualitative study to elicit the views of policy makers and thought leaders
  73. Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985–2006
  74. Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study
  75. Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland
  76. Forecasting future prevalence of type 2 diabetes mellitus in Syria
  77. Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020
  78. Analyzing Recent Coronary Heart Disease Mortality Trends in Tunisia between 1997 and 2009
  79. Unequal Trends in Coronary Heart Disease Mortality by Socioeconomic Circumstances, England 1982–2006: An Analytical Study
  80. The UK National Health Service: Delivering Equitable Treatment Across the Spectrum of Coronary Disease
  81. e-Labs and the Stock of Health Method for Simulating Health Policies
  82. Remarkable Decline in Ischemic Stroke Mortality is Not Matched by Changes in Incidence
  83. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007
  84. Forecasting prevalence of type 2 diabetes mellitus in Palestinians to 2030: validation of a predictive model
  85. Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s?
  86. Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006
  87. The International Diabetes Federation: losing its credibility by partnering with Nestlé?
  88. Recent UK trends in the unequal burden of coronary heart disease
  89. Community Care in England: Reducing Socioeconomic Inequalities in Heart Failure
  90. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976–2006): A time trend analysis
  91. New perspectives on cardiovascular risk in individuals and in populations
  92. Analysing Recent Socioeconomic Trends in Coronary Heart Disease Mortality in England, 2000–2007: A Population Modelling Study
  93. Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland
  94. Very young adolescents and alcohol: Evidence of a unique susceptibility to peer alcohol use
  95. Modelling coronary heart disease mortality in Northern Ireland between 1987 and 2007: broader lessons for prevention
  96. Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: A time-trend analysis of repeated cross-sectional data
  97. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study
  98. Barriers to Partnership Working in Public Health: A Qualitative Study
  99. How Important Is the Context of an Adolescent’s First Alcoholic Drink? Evidence that Parental Provision May Reduce Later Heavy Episodic Drinking
  100. Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009
  101. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005
  102. Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality
  103. Prioritising public health: a qualitative study of decision making to reduce health inequalities
  104. The Influence of Families on Early Adolescent School Connectedness: Evidence That This Association Varies with Adolescent Involvement in Peer Drinking Networks
  105. IMPACT: A Generic Tool for Modelling and Simulating Public Health Policy
  106. Rapid mortality falls after risk-factor changes in populations
  107. The Use of Research Evidence in Public Health Decision Making Processes: Systematic Review
  108. Can dietary changes rapidly decrease cardiovascular mortality rates?
  109. Coronary heart disease mortality trends in the Netherlands 1972-2007
  110. Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada
  111. Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006
  112. Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005
  113. IMPACT: A generalisable system for simulating public health interventions
  114. Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study
  115. Trends in cardiovascular disease: Are we winning the war?
  116. Potential Reductions in United States Coronary Heart Disease Mortality by Treating More Patients
  117. Planning ahead in public health? A qualitative study of the time horizons used in public health decision-making
  118. Pace of change in coronary heart disease mortality in Finland, Ireland and the United Kingdom from 1985 to 2006
  119. Policy-makers’ attitudes to decision support models for coronary heart disease: A qualitative study
  120. What explains declining coronary mortality? Lessons and warnings
  121. Hypertensive Urgencies in the Emergency Department: Evaluating Blood Pressure Response to Rest and to Antihypertensive Drugs With Different Profiles
  122. Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats
  123. Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline
  124. The author's reply:
  125. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults
  126. Maximising secondary prevention therapies in patients with coronary heart disease
  127. Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension
  128. A simple prediction rule identified patients with pulmonary embolism at low risk of short term death
  129. A haemoglobin concentration of 140 g/l was associated with a lower mortality risk than concentrations <=120 g/l in older women with disabilities
  130. Testicular Anti-Müllerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism
  131. A bedside prediction tool predicted all cause mortality 6 months after discharge for acute coronary syndrome
  132. Quality and methods of developing practice guidelines
  133. Reliability of Secondary Central Coding of Medical Problems in Primary Care by Non-medical Coders, using the International Classification of Primary Care (ICPC)
  134. Lack of effective blood pressure control among an elder hypertensive population in Buenos Aires